NicA2 Enzyme Biosensor for Real-Time Nicotine Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for nicotine detection are limited by their inability to provide real-time, continuous, and specific measurement of nicotine levels at physiological ranges, especially in point-of-care settings, and are not cost-effective for widespread use.
Innovation Solution
Development of an amperometric biosensor using a nicotine-catalyzing enzyme, NicA2, electronically coupled with a redox mediator, which catalyzes nicotine to produce hydrogen peroxide, enabling real-time and continuous detection of nicotine levels in bodily fluids and air.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mass spectroscopy analysis is used for nicotine measurement, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The patent replaces complex mass spectroscopy analysis with a simplified electrochemical biosensor system. The biosensor uses enzyme-catalyzed reactions coupled with electrochemical detection to measure nicotine, eliminating the need for expensive and complex mass spectroscopy instrumentation while maintaining sufficient measurement precision for clinical applications.
Solution Approach 2:
The patent introduces intermediary components including a redox mediator (such as ferricyanide/ferrocyanide couple) and enzyme catalysts that facilitate nicotine detection through electrochemical reactions. These intermediaries enable the conversion of nicotine presence into measurable electrical signals without requiring direct mass spectroscopy analysis.
2Ease of operation
If antibody-based nicotine detection kits are used, then ease of operation is improved, but measurement precision and continuous monitoring capability deteriorate
Solution Approach 1:
The patent replaces antibody-based immunological detection with an electrochemical biosensor system that provides both ease of operation and continuous monitoring capability. The biosensor maintains simplicity similar to antibody kits while adding the ability to continuously measure nicotine levels and provide quantitative data through electrochemical signals.
3Measurement precision
If gas or liquid chromatography-mass spectrometry is used for quantitative nicotine measurement, then measurement precision is improved, but productivity and accessibility worsen
Solution Approach 1:
The patent replaces time-consuming chromatography-mass spectrometry methods with rapid electrochemical biosensing. The biosensor provides quantitative nicotine measurements directly in bodily fluids without requiring sample preparation for chromatography, significantly reducing detection time and improving accessibility to point-of-care settings.
4Ease of manufacture
If one-time use nicotine detection kits are used, then manufacturing cost is reduced, but reliability and continuous monitoring capability deteriorate
Solution Approach 1:
The patent implements a biosensor system capable of continuous nicotine monitoring through sustained electrochemical detection. The biosensor maintains active enzyme layers and redox mediators that continuously convert nicotine presence into electrical signals, enabling long-term reliable monitoring rather than single-use detection, while remaining cost-effective for widespread deployment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor provides specific, real-time, and continuous measurement of nicotine levels, is cost-effective, and can detect nicotine in a wide range of concentrations, including those relevant to smokers and passive exposure, without cross-reacting with cotinine, enabling effective monitoring and treatment strategies.
Implementation Method 1
a nicotine-catalyzing enzyme, NicA2, electronically coupled with a redox mediator, which catalyzes nicotine to produce hydrogen peroxide
Implementation Method 2
electronically coupled with a redox mediator, which catalyzes nicotine to produce hydrogen peroxide, enabling real-time and continuous detection
Data Source
AI summary
Described herein is an amperometric biosensor, e.g., chronoamperometric biosensor for the measurement of the concentration of nicotine. Also disclosed herein is a wearable nicotine biosensor device and a biosensor that detects nicotine in smoke. The biosensor disclosed herein comprises a nicotine-catalyzing enzyme, such as NicA2 or mutant NicA2 enzymes. Also described herein are systems comprising said amperometric biosensor, e.g., chronoamperometric biosensor and methods of using said chronoamperometric biosensor.